BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33220611)

  • 21. Definitive chemoradiation for locoregional recurrences of esophageal cancer after primary curative treatment.
    Jeene PM; Versteijne E; van Berge Henegouwen MI; Bergmann JJ; Geijsen ED; Muller K; van Laarhoven HW; Hulshof MC
    Dis Esophagus; 2017 Feb; 30(2):1-5. PubMed ID: 27766725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer.
    Taugner J; Eze C; Käsmann L; Roengvoraphoj O; Gennen K; Karin M; Petrukhnov O; Tufman A; Belka C; Manapov F
    Radiat Oncol; 2020 Jun; 15(1):148. PubMed ID: 32517716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salvage surgery for local recurrence after sublobar surgery in Stages I and II non-small cell lung cancer.
    Dolan DP; Lee DN; Kucukak S; De León LE; Bueno R; Jaklitsch MT; Swanson SJ; White A
    J Surg Oncol; 2022 Sep; 126(4):814-822. PubMed ID: 35603966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathologic response rates following definitive dose image-guided chemoradiotherapy and resection for locally advanced non-small cell lung cancer.
    Shumway D; Corbin K; Salgia R; Hoffman P; Villaflor V; Malik RM; Haraf DJ; Vigneswaren WT; Shaikh AY; Connell PP; Ferguson MK; Salama JK
    Lung Cancer; 2011 Dec; 74(3):446-50. PubMed ID: 21676484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Propensity score adjusted analysis of patients with isolated locoregional recurrence versus de novo locally advanced NSCLC treated with definitive therapy.
    Friedes C; Mai N; Fu W; Hu C; Han P; Marrone KA; Voong KR; Hales RK
    Lung Cancer; 2020 Jul; 145():119-125. PubMed ID: 32434118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Radiotherapy and Chemoradiotherapy for Locoregional Recurrence of Non-small-cell Lung Cancer Developing After Surgery.
    Nakamichi S; Horinouchi H; Asao T; Goto Y; Kanda S; Fujiwara Y; Nokihara H; Yamamoto N; Ito Y; Watanabe SI; Ohe Y
    Clin Lung Cancer; 2017 Nov; 18(6):e441-e448. PubMed ID: 28583380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [When Should We Perform Surgery for N2 Lung Cancer?;Induction Chemoradiotherapy or Surgery for Local Recurrence or Residual Tumor after Definitive Chemoradiotherapy].
    Ito H; Nakayama H
    Kyobu Geka; 2018 Apr; 71(4):290-299. PubMed ID: 29755103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Equivalent Outcome of Patients with Locally Advanced NSCLC Treated with Salvage Surgery Compared to Induction Chemotherapy Followed by Surgical Resection.
    Uramoto H; Nakajima Y; Kinoshita H; Akiyama H
    Anticancer Res; 2016 Aug; 36(8):4243-7. PubMed ID: 27466539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined treatment modalities in Pancoast tumor: results of a monocentric retrospective study.
    Jeannin G; Merle P; Janicot H; Thibonnier L; Kwiatkowski F; Naame A; Chadeyras JB; Galvaing G; Belliere A; Filaire M; Verrelle P
    Chin Clin Oncol; 2015 Dec; 4(4):39. PubMed ID: 26730751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Salvage Surgery for Residual and Recurred Tumor after Definitive Chemoradiotherapy].
    Ito H; Nakayama H
    Kyobu Geka; 2017 Oct; 70(11):915-920. PubMed ID: 29038403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salvage Surgery Compared to Surgery After Induction Chemoradiation Therapy for Advanced Lung Cancer.
    Kobayashi AK; Nakagawa K; Nakayama Y; Ohe Y; Yotsukura M; Uchida S; Asakura K; Yoshida Y; Watanabe SI
    Ann Thorac Surg; 2022 Dec; 114(6):2087-2092. PubMed ID: 34843695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salvage surgery for recurrent or persistent tumour after radical (chemo)radiotherapy for locally advanced non-small cell lung cancer: a systematic review.
    Dickhoff C; Otten RHJ; Heymans MW; Dahele M
    Ther Adv Med Oncol; 2018; 10():1758835918804150. PubMed ID: 30305851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salvage surgery after chemotherapy and/or radiotherapy including SBRT and proton therapy: A consecutive analysis of 38 patients.
    Kobayashi AK; Horinouchi H; Nakayama Y; Ohe Y; Yotsukura M; Uchida S; Asakura K; Yoshida Y; Nakagawa K; Watanabe SI
    Lung Cancer; 2020 Jul; 145():105-110. PubMed ID: 32422344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases.
    Bowne WB; Lee B; Wong WD; Ben-Porat L; Shia J; Cohen AM; Enker WE; Guillem JG; Paty PB; Weiser MR
    Dis Colon Rectum; 2005 May; 48(5):897-909. PubMed ID: 15785892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative concurrent chemoradiotherapy followed by extrapleural pneumonectomy for patients with non-small cell lung cancer with malignant pleural effusion and/or pleural nodules: Ten-year results of a prematurely terminated single institute phase II trial.
    Yamaguchi M; Ichinose Y; Shimamatsu S; Yoshida T; Toyokawa G; Nosaki K; Hirai F; Seto T; Takenoyama M
    Surg Oncol; 2015 Jun; 24(2):78-83. PubMed ID: 25818753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salvage endoscopic resection (ER) after chemoradiotherapy for esophageal squamous cell carcinoma: What are the risk factors for recurrence after salvage ER?
    Hombu T; Yano T; Hatogai K; Kojima T; Kadota T; Onozawa M; Yoda Y; Hori K; Oono Y; Ikematsu H; Fujii S
    Dig Endosc; 2018 May; 30(3):338-346. PubMed ID: 29106753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors in neoadjuvant treatment followed by surgery in stage IIIA-N2 non-small cell lung cancer: a multi-institutional study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society).
    Couñago F; Montemuiño S; Martin M; Taboada B; Calvo-Crespo P; Samper-Ots MP; Alcántara P; Corona J; López-Guerra JL; Murcia-Mejía M; López-Mata M; Jové-Teixidó J; Chust M; Díaz-Díaz V; de Ingunza-Barón L; García-Cañibano T; Couselo ML; Del Cerro E; Moradiellos J; Amor S; Varela A; Puertas MM; Thuissard IJ; Sanz-Rosa D; de Dios NR
    Clin Transl Oncol; 2019 Jun; 21(6):735-744. PubMed ID: 30430394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Locoregional Recurrence of Esophageal Cancer Treated with Curative Intent Local Salvage Therapy: A Single Center Experience.
    Grou-Boileau F; Tankel J; Nevo Y; Najmeh S; Spicer J; Cools-Lartigue J; Mueller C; Ferri L
    J Gastrointest Cancer; 2023 Dec; 54(4):1292-1299. PubMed ID: 36988820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemoradiotherapy for locoregional recurrence of non-small-cell lung cancer after surgical resection: a retrospective analysis.
    Bar J; Ng D; Moretto P; Goss GD; Sun A; Macrae R; Laurie SA; Leighl N; Nicholas G
    Clin Lung Cancer; 2013 Mar; 14(2):200-4. PubMed ID: 22868221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.